Matches in SemOpenAlex for { <https://semopenalex.org/work/W3167287181> ?p ?o ?g. }
- W3167287181 endingPage "e2116420" @default.
- W3167287181 startingPage "e2116420" @default.
- W3167287181 abstract "Multisystem inflammatory syndrome in children (MIS-C) is associated with recent or current SARS-CoV-2 infection. Information on MIS-C incidence is limited.To estimate population-based MIS-C incidence per 1 000 000 person-months and to estimate MIS-C incidence per 1 000 000 SARS-CoV-2 infections in persons younger than 21 years.This cohort study used enhanced surveillance data to identify persons with MIS-C during April to June 2020, in 7 jurisdictions reporting to both the Centers for Disease Control and Prevention national surveillance and to Overcoming COVID-19, a multicenter MIS-C study. Denominators for population-based estimates were derived from census estimates; denominators for incidence per 1 000 000 SARS-CoV-2 infections were estimated by applying published age- and month-specific multipliers accounting for underdetection of reported COVID-19 case counts. Jurisdictions included Connecticut, Georgia, Massachusetts, Michigan, New Jersey, New York (excluding New York City), and Pennsylvania. Data analyses were conducted from August to December 2020.Race/ethnicity, sex, and age group (ie, ≤5, 6-10, 11-15, and 16-20 years).Overall and stratum-specific adjusted estimated MIS-C incidence per 1 000 000 person-months and per 1 000 000 SARS-CoV-2 infections.In the 7 jurisdictions examined, 248 persons with MIS-C were reported (median [interquartile range] age, 8 [4-13] years; 133 [53.6%] male; 96 persons [38.7%] were Hispanic or Latino; 75 persons [30.2%] were Black). The incidence of MIS-C per 1 000 000 person-months was 5.1 (95% CI, 4.5-5.8) persons. Compared with White persons, incidence per 1 000 000 person-months was higher among Black persons (adjusted incidence rate ratio [aIRR], 9.26 [95% CI, 6.15-13.93]), Hispanic or Latino persons (aIRR, 8.92 [95% CI, 6.00-13.26]), and Asian or Pacific Islander (aIRR, 2.94 [95% CI, 1.49-5.82]) persons. MIS-C incidence per 1 000 000 SARS-CoV-2 infections was 316 (95% CI, 278-357) persons and was higher among Black (aIRR, 5.62 [95% CI, 3.68-8.60]), Hispanic or Latino (aIRR, 4.26 [95% CI, 2.85-6.38]), and Asian or Pacific Islander persons (aIRR, 2.88 [95% CI, 1.42-5.83]) compared with White persons. For both analyses, incidence was highest among children aged 5 years or younger (4.9 [95% CI, 3.7-6.6] children per 1 000 000 person-months) and children aged 6 to 10 years (6.3 [95% CI, 4.8-8.3] children per 1 000 000 person-months).In this cohort study, MIS-C was a rare complication associated with SARS-CoV-2 infection. Estimates for population-based incidence and incidence among persons with infection were higher among Black, Hispanic or Latino, and Asian or Pacific Islander persons. Further study is needed to understand variability by race/ethnicity and age group." @default.
- W3167287181 created "2021-06-22" @default.
- W3167287181 creator A5000071831 @default.
- W3167287181 creator A5000189223 @default.
- W3167287181 creator A5001314267 @default.
- W3167287181 creator A5001809529 @default.
- W3167287181 creator A5002626989 @default.
- W3167287181 creator A5003288915 @default.
- W3167287181 creator A5003536351 @default.
- W3167287181 creator A5004502885 @default.
- W3167287181 creator A5005768522 @default.
- W3167287181 creator A5007406049 @default.
- W3167287181 creator A5009301455 @default.
- W3167287181 creator A5009351866 @default.
- W3167287181 creator A5009373393 @default.
- W3167287181 creator A5012356355 @default.
- W3167287181 creator A5014871209 @default.
- W3167287181 creator A5015714770 @default.
- W3167287181 creator A5018285545 @default.
- W3167287181 creator A5021170224 @default.
- W3167287181 creator A5021226785 @default.
- W3167287181 creator A5021780107 @default.
- W3167287181 creator A5025019811 @default.
- W3167287181 creator A5026772153 @default.
- W3167287181 creator A5030055621 @default.
- W3167287181 creator A5033749554 @default.
- W3167287181 creator A5039583801 @default.
- W3167287181 creator A5039617494 @default.
- W3167287181 creator A5040660622 @default.
- W3167287181 creator A5042271212 @default.
- W3167287181 creator A5046582287 @default.
- W3167287181 creator A5047881103 @default.
- W3167287181 creator A5048224712 @default.
- W3167287181 creator A5049562689 @default.
- W3167287181 creator A5053435953 @default.
- W3167287181 creator A5053525319 @default.
- W3167287181 creator A5053578480 @default.
- W3167287181 creator A5054619571 @default.
- W3167287181 creator A5055274627 @default.
- W3167287181 creator A5056531761 @default.
- W3167287181 creator A5057388859 @default.
- W3167287181 creator A5060489991 @default.
- W3167287181 creator A5060730934 @default.
- W3167287181 creator A5062635590 @default.
- W3167287181 creator A5064650836 @default.
- W3167287181 creator A5066889666 @default.
- W3167287181 creator A5069406522 @default.
- W3167287181 creator A5069821127 @default.
- W3167287181 creator A5071148283 @default.
- W3167287181 creator A5072203438 @default.
- W3167287181 creator A5072931455 @default.
- W3167287181 creator A5073278312 @default.
- W3167287181 creator A5075266030 @default.
- W3167287181 creator A5076936771 @default.
- W3167287181 creator A5079695343 @default.
- W3167287181 creator A5079894302 @default.
- W3167287181 creator A5084516978 @default.
- W3167287181 creator A5084791520 @default.
- W3167287181 creator A5085148553 @default.
- W3167287181 creator A5085496518 @default.
- W3167287181 creator A5086158763 @default.
- W3167287181 creator A5086396830 @default.
- W3167287181 creator A5086708552 @default.
- W3167287181 creator A5087750390 @default.
- W3167287181 creator A5088350249 @default.
- W3167287181 creator A5088560766 @default.
- W3167287181 creator A5088663182 @default.
- W3167287181 creator A5089135490 @default.
- W3167287181 creator A5091740212 @default.
- W3167287181 creator A5091823317 @default.
- W3167287181 date "2021-06-10" @default.
- W3167287181 modified "2023-10-18" @default.
- W3167287181 title "Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2" @default.
- W3167287181 cites W3009885589 @default.
- W3167287181 cites W3010819577 @default.
- W3167287181 cites W3014199470 @default.
- W3167287181 cites W3014206579 @default.
- W3167287181 cites W3014361632 @default.
- W3167287181 cites W3024521558 @default.
- W3167287181 cites W3031583784 @default.
- W3167287181 cites W3032824264 @default.
- W3167287181 cites W3033880976 @default.
- W3167287181 cites W3033944327 @default.
- W3167287181 cites W3037731101 @default.
- W3167287181 cites W3038003713 @default.
- W3167287181 cites W3047454876 @default.
- W3167287181 cites W3047926481 @default.
- W3167287181 cites W3093493898 @default.
- W3167287181 cites W3095050870 @default.
- W3167287181 cites W3107831315 @default.
- W3167287181 cites W3108092863 @default.
- W3167287181 cites W3110046534 @default.
- W3167287181 cites W3112645083 @default.
- W3167287181 cites W3144463172 @default.
- W3167287181 doi "https://doi.org/10.1001/jamanetworkopen.2021.16420" @default.
- W3167287181 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8193431" @default.
- W3167287181 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34110391" @default.
- W3167287181 hasPublicationYear "2021" @default.